ATIM-07. STUDY OF PEMBROLIZUMAB, TUMOR TREATMENT FIELDS (OPTUNE®) AND TEMOZOLOMIDE FOR OLDER SUBJECTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Given the median age of diagnosis in glioblastoma is 65 years, a sizable proportion of cases occur in the elderly population. One of the most feared complications of radiation in elderly patients is cognitive decline due to radiation-induced neurotoxicity, which can be irreversible, extremely debili...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Donovan, Laura, Cieremans, David, Kreisl, Teri, Welch, Mary, Lassman, Andrew B, Iwamoto, Fabio
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692257/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.103
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky